Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Wolf

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
The Journal of Infectious Diseases|March 9, 1999
Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected personsF W Wit, R van Leeuwen, G J Weverling, et al.
Molecular Pharmacology|October 13, 2006
The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport modelsPauline Breedveld, Dick Pluim, Greta Cipriani, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 6, 2017
Editor's Choice - Reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstructionT M A J van Vuuren, M A F de Wolf, C W K P Arnoldussen, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 11, 2024
Venous Stents Placed for Postthrombotic Syndrome: The Role of Inflow Disease on PatencyJay M Bakas, Mark A F de Wolf, Renate R van den Bos, et al.
AIDS (London, England)|February 10, 1998
Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapyN A Foudraine, G J Weverling, T van Gool, et al.
Science (New York, N.Y.)|November 29, 1996
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnoverK C Wolthers, G Bea, A Wisman, et al.
Annals of Internal Medicine|February 12, 1998
Association between CCR5 genotype and the clinical course of HIV-1 infectionA M de Roda Husman, M Koot, M Cornelissen, et al.
Lancet (London, England)|July 31, 1998
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) studyM H Reijers, G J Weverling, S Jurriaans, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 5, 2011
Stability, survival, and tolerability of a novel baha implant system: six-month data from a multicenter clinical investigationCatharina A J Dun, Maarten J F de Wolf, Myrthe K S Hol, et al.
AIDS (London, England)|February 19, 1998
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study GroupD W Notermans, S Jurriaans, F de Wolf, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
The Journal of Infectious Diseases|March 9, 1999
Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected personsF W Wit, R van Leeuwen, G J Weverling, et al.
Molecular Pharmacology|October 13, 2006
The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport modelsPauline Breedveld, Dick Pluim, Greta Cipriani, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 6, 2017
Editor's Choice - Reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstructionT M A J van Vuuren, M A F de Wolf, C W K P Arnoldussen, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 11, 2024
Venous Stents Placed for Postthrombotic Syndrome: The Role of Inflow Disease on PatencyJay M Bakas, Mark A F de Wolf, Renate R van den Bos, et al.
AIDS (London, England)|February 10, 1998
Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapyN A Foudraine, G J Weverling, T van Gool, et al.
Science (New York, N.Y.)|November 29, 1996
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnoverK C Wolthers, G Bea, A Wisman, et al.
Annals of Internal Medicine|February 12, 1998
Association between CCR5 genotype and the clinical course of HIV-1 infectionA M de Roda Husman, M Koot, M Cornelissen, et al.
Lancet (London, England)|July 31, 1998
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) studyM H Reijers, G J Weverling, S Jurriaans, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 5, 2011
Stability, survival, and tolerability of a novel baha implant system: six-month data from a multicenter clinical investigationCatharina A J Dun, Maarten J F de Wolf, Myrthe K S Hol, et al.
AIDS (London, England)|February 19, 1998
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study GroupD W Notermans, S Jurriaans, F de Wolf, et al.
Pageof 19